Gastric Cancer Metastasized to the Central Nervous System (CNS)

Registry of Gastric Cancer and Brain Metastases

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01456455

Enrollment

150

Registered

2011-10-20

Start date

2011-08-31

Completion date

2020-08-31

Last updated

2016-10-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Cancer

Keywords

Central nervous system, pathological markers

Brief summary

Descriptive registry to investigate frequency of HER-2 positive gastric cancer involving CNS. Exploration of additional prognostic factors for brain involvement from gastric cancer.

Detailed description

HER2 Status E-Cadherin Status

Interventions

None listed

Study design

Observational model

COHORT

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* in order to be eligible for the study, the diagnosis of gastric cancer and/or lower esophageal cancer must be confirmed histologically. CNS involvement must be confirmed either via independent neuroradiological and/or positive CSF cytology.

Exclusion criteria

* Patients whose diagnosis is not confirmed upon pathological review or where the CNS involvement cannot be confirmed after neuroradiological review will be excluded from this study.

Design outcomes

Primary

Measure	Time frame	Description
HER2 Status	2 years	Determination of HER2 Status on Tumor Tissue

Secondary

Measure	Time frame
Outcome according to HER2 Status	2 years

Other

Measure	Time frame
Outcome according to ethnicity of patients	2 years

Countries

Switzerland

Outcome results